Bristol Myers Squibb (BMY) Other Accumulated Expenses (2009 - 2026)
Bristol Myers Squibb (BMY) posted Other Accumulated Expenses of $13.47 billion for Q2 2026, down 22.5% from $17.39 billion a year earlier but up 6.8% from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) Other Accumulated Expenses (2009 - 2026) Analysis & Trends
At the end of FY2025, Bristol Myers Squibb's Other Accumulated Expenses came in at $17.58 billion, down 3.0% from FY2024.
- Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 4.6% (FY2020 to FY2025).
- In prior years, Bristol Myers Squibb's Other Accumulated Expenses was $18.13 billion in FY2024 (+14.1%), $15.88 billion in FY2023 (+8.9%), $14.59 billion in FY2022 (+4.4%) and $13.97 billion in FY2021 (-0.4%).
- Quarterly Other Accumulated Expenses has run from a low of $12.36 billion in Q1 2022 to a high of $19.34 billion in Q3 2025 over five years.
- On a year-over-year basis, Other Accumulated Expenses has declined in each of the last three quarters, with growth averaging 0.3% over the last eight quarters.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q1 2024, with growth of 22.5%; the weakest was Q1 2026, with a decline of 23.6%.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $12.62 billion (Q1 2026), $17.58 billion (Q4 2025) and $19.34 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn |
| 10 | Bristol Myers Squibb | 125.99 Bn | 77.26 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.47 Bn |
| Mar 31, 2026 | 12.62 Bn |
| Dec 31, 2025 | 17.58 Bn |
| Sep 30, 2025 | 19.34 Bn |
| Jun 30, 2025 | 17.39 Bn |
| Mar 31, 2025 | 16.51 Bn |
| Dec 31, 2024 | 18.13 Bn |
| Sep 30, 2024 | 18.09 Bn |
| Jun 30, 2024 | 15.98 Bn |
| Mar 31, 2024 | 16.09 Bn |
| Dec 31, 2023 | 15.88 Bn |
| Sep 30, 2023 | 15.18 Bn |
| Jun 30, 2023 | 14.06 Bn |
| Mar 31, 2023 | 13.14 Bn |
| Dec 31, 2022 | 14.59 Bn |
| Sep 30, 2022 | 14.20 Bn |
| Jun 30, 2022 | 13.08 Bn |
| Mar 31, 2022 | 12.36 Bn |
| Dec 31, 2021 | 13.97 Bn |
| Sep 30, 2021 | 13.70 Bn |
API Access
Bristol Myers Squibb Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();